0001140361-16-088121.txt : 20161129 0001140361-16-088121.hdr.sgml : 20161129 20161129203403 ACCESSION NUMBER: 0001140361-16-088121 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161125 FILED AS OF DATE: 20161129 DATE AS OF CHANGE: 20161129 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOMARIN PHARMACEUTICAL INC CENTRAL INDEX KEY: 0001048477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 680397820 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 4155066700 MAIL ADDRESS: STREET 1: 105 DIGITAL DRIVE CITY: NOVATO STATE: CA ZIP: 94949 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FUCHS HENRY J CENTRAL INDEX KEY: 0001197355 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26727 FILM NUMBER: 162023875 MAIL ADDRESS: STREET 1: C/O INTRABIOTICS PHARMACEUTICALS INC STREET 2: 1245 TERRA BELLA AVENUE CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 4 1 doc1.xml FORM 4 X0306 4 2016-11-25 0 0001048477 BIOMARIN PHARMACEUTICAL INC BMRN 0001197355 FUCHS HENRY J C/O BIOMARIN PHARMACEUTICAL INC. 770 LINDARO ST. SAN RAFAEL CA 94901 0 1 0 0 President, Worldwide R&D Common Stock 2016-11-25 2016-11-25 4 M 0 15000 26.49 A 128878 D Common Stock 2016-11-25 2016-11-25 4 S 0 15000 87.3992 D 113878 D Stock Option (Right to buy Common Stock) 26.49 2016-11-25 2016-11-25 4 M 0 15000 0 D 2011-11-12 2021-05-11 Common Stock 15000 35225 D Trade made pursuant to a 10b5-1 plan executed on May 12, 2016. The price in column 4 is the weighted average price. The price actually received ranged from $86.67 to $88.06. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Reflects the number of stock options outstanding after the transaction from this specific stock option grant. /s/ Laura Randall Woodhead, Attorney-in-Fact 2016-11-29